朝聚眼科医疗控股有限公司（02219）于2026年1月27日发布翌日披露报表，公告显示公司当日于香港联交所回购6万股普通股，约占已发行股本的0.008%。本次回购价格区间为每股2.69港元至2.71港元，涉及总金额约16.2万港元。回购后，公司已发行股本仍为707,510,500股，该等回购股份尚未注销。
根据公告，本次回购依据2025年6月6日通过的购回授权进行，授权可购回股份总数为70,751,050股，公司迄今已在交易所累计购回2,270,000股，占授权通过时已发行股本的0.32%。公司确认已遵守所有适用的上市规则及相关法律法规。
本公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.